Evolus Inc (NASDAQ: EOLS) kicked off on Friday, down -3.37% from the previous trading day, before settling in for the closing price of $13.04. Over the past 52 weeks, EOLS has traded in a range of $9.29-$17.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 44.65%. While this was happening, its average annual earnings per share was recorded 63.89%. With a float of $54.65 million, this company’s outstanding shares have now reached $57.82 million.
Considering the fact that the conglomerate employs 273 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 68.25%, operating margin of -13.69%, and the pretax margin is -22.2%.
Evolus Inc (EOLS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Evolus Inc is 13.69%, while institutional ownership is 79.68%. The most recent insider transaction that took place on Sep 06 ’24, was worth 49,074. In this transaction Chief Financial Officer of this company sold 3,276 shares at a rate of $14.98, taking the stock ownership to the 148,502 shares. Before that another transaction happened on Aug 30 ’24, when Company’s Chief Marketing Officer sold 5,631 for $15.85, making the entire transaction worth $89,251. This insider now owns 82,375 shares in total.
Evolus Inc (EOLS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.14 earnings per share (EPS), lower than consensus estimate (set at -0.07) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.50% during the next five years compared to 10.81% growth over the previous five years of trading.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Take a look at Evolus Inc’s (EOLS) current performance indicators. Last quarter, stock had a quick ratio of 2.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach -0.03 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Compared to the last year’s volume of 0.6 million, its volume of 0.68 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 58.14%. Additionally, its Average True Range was 0.76.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 26.17%, which indicates a significant increase from 20.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.75% in the past 14 days, which was higher than the 53.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.58, while its 200-day Moving Average is $13.73. Nevertheless, the first resistance level for the watch stands at $13.08 in the near term. At $13.55, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.86. If the price goes on to break the first support level at $12.29, it is likely to go to the next support level at $11.98. Now, if the price goes above the second support level, the third support stands at $11.51.
Evolus Inc (NASDAQ: EOLS) Key Stats
The company with the Market Capitalisation of 770.93 million has total of 63,321K Shares Outstanding. Its annual sales at the moment are 202,090 K in contrast with the sum of -61,690 K annual income. Company’s last quarter sales were recorded 61,090 K and last quarter income was -19,170 K.
